FibroGen Total Assets from 2010 to 2024

FGEN Stock  USD 1.17  0.05  4.46%   
FibroGen Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to grow to about 665.2 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2012-12-31
Previous Quarter
460.4 M
Current Value
423.5 M
Quarterly Volatility
201.1 M
 
Yuan Drop
 
Covid
Check FibroGen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FibroGen main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.5 M, Interest Expense of 16.3 M or Selling General Administrative of 82.7 M, as well as many exotic indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0 or Days Sales Outstanding of 106. FibroGen financial statements analysis is a perfect complement when working with FibroGen Valuation or Volatility modules.
  
This module can also supplement FibroGen's financial leverage analysis and stock options assessment as well as various FibroGen Technical models . Check out the analysis of FibroGen Correlation against competitors.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.

Latest FibroGen's Total Assets Growth Pattern

Below is the plot of the Total Assets of FibroGen over the last few years. Total assets refers to the total amount of FibroGen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in FibroGen books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. FibroGen's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in FibroGen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 423.53 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

FibroGen Total Assets Regression Statistics

Arithmetic Mean563,568,509
Geometric Mean512,617,978
Coefficient Of Variation42.58
Mean Deviation209,019,876
Median483,528,000
Standard Deviation239,956,364
Sample Variance57579.1T
Range633.1M
R-Value0.64
Mean Square Error36743.4T
R-Squared0.41
Significance0.01
Slope34,249,209
Total Sum of Squares806106.8T

FibroGen Total Assets History

2024665.2 M
2023423.5 M
2022610.1 M
2021773.8 M
2020826.8 M
2019857.4 M
2018880.6 M

Other Fundumenentals of FibroGen

FibroGen Total Assets component correlations

0.640.35-0.59-0.40.44-0.70.520.640.510.970.320.81-0.450.55-0.41-0.560.07-0.410.67-0.16-0.20.22
0.64-0.16-0.610.41-0.16-0.480.220.32-0.190.590.220.21-0.140.960.14-0.03-0.530.170.030.630.59-0.58
0.35-0.160.0-0.570.6-0.270.360.330.730.280.220.630.21-0.32-0.3-0.210.31-0.270.48-0.53-0.570.44
-0.59-0.610.00.01-0.270.26-0.080.16-0.14-0.65-0.48-0.40.38-0.56-0.120.450.170.15-0.29-0.18-0.210.08
-0.40.41-0.570.01-0.780.24-0.43-0.39-0.9-0.47-0.05-0.750.470.450.730.66-0.790.8-0.870.960.96-0.96
0.44-0.160.6-0.27-0.78-0.050.320.280.880.48-0.030.71-0.44-0.3-0.67-0.460.33-0.810.79-0.7-0.720.69
-0.7-0.48-0.270.260.24-0.05-0.44-0.57-0.26-0.67-0.46-0.560.23-0.460.190.43-0.150.09-0.410.060.09-0.08
0.520.220.36-0.08-0.430.32-0.440.640.410.58-0.230.54-0.430.24-0.68-0.490.42-0.340.59-0.28-0.280.31
0.640.320.330.16-0.390.28-0.570.640.460.61-0.140.56-0.230.27-0.61-0.30.13-0.340.56-0.24-0.310.18
0.51-0.190.73-0.14-0.90.88-0.260.410.460.550.140.86-0.35-0.32-0.64-0.570.57-0.810.89-0.81-0.830.76
0.970.590.28-0.65-0.470.48-0.670.580.610.550.30.82-0.570.53-0.45-0.70.16-0.490.75-0.22-0.240.28
0.320.220.22-0.48-0.05-0.03-0.46-0.23-0.140.140.30.350.080.130.51-0.36-0.010.060.040.060.07-0.04
0.810.210.63-0.4-0.750.71-0.560.540.560.860.820.35-0.490.07-0.54-0.690.44-0.70.86-0.55-0.570.57
-0.45-0.140.210.380.47-0.440.23-0.43-0.23-0.35-0.570.08-0.49-0.150.620.57-0.320.75-0.580.320.29-0.47
0.550.96-0.32-0.560.45-0.3-0.460.240.27-0.320.530.130.07-0.150.15-0.02-0.440.25-0.010.660.62-0.58
-0.410.14-0.3-0.120.73-0.670.19-0.68-0.61-0.64-0.450.51-0.540.620.150.36-0.50.75-0.760.660.69-0.69
-0.56-0.03-0.210.450.66-0.460.43-0.49-0.3-0.57-0.7-0.36-0.690.57-0.020.36-0.550.49-0.680.540.45-0.56
0.07-0.530.310.17-0.790.33-0.150.420.130.570.16-0.010.44-0.32-0.44-0.5-0.55-0.510.62-0.81-0.780.82
-0.410.17-0.270.150.8-0.810.09-0.34-0.34-0.81-0.490.06-0.70.750.250.750.49-0.51-0.830.70.72-0.75
0.670.030.48-0.29-0.870.79-0.410.590.560.890.750.040.86-0.58-0.01-0.76-0.680.62-0.83-0.73-0.750.73
-0.160.63-0.53-0.180.96-0.70.06-0.28-0.24-0.81-0.220.06-0.550.320.660.660.54-0.810.7-0.730.99-0.97
-0.20.59-0.57-0.210.96-0.720.09-0.28-0.31-0.83-0.240.07-0.570.290.620.690.45-0.780.72-0.750.99-0.96
0.22-0.580.440.08-0.960.69-0.080.310.180.760.28-0.040.57-0.47-0.58-0.69-0.560.82-0.750.73-0.97-0.96
Click cells to compare fundamentals

About FibroGen Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include FibroGen income statement, its balance sheet, and the statement of cash flows. FibroGen investors use historical funamental indicators, such as FibroGen's Total Assets, to determine how well the company is positioned to perform in the future. Although FibroGen investors may use each financial statement separately, they are all related. The changes in FibroGen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on FibroGen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on FibroGen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in FibroGen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets423.5 M665.2 M
Intangibles To Total Assets 0.00  0.00 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock:
Check out the analysis of FibroGen Correlation against competitors.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for FibroGen Stock analysis

When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.536
Earnings Share
(2.92)
Revenue Per Share
1.518
Quarterly Revenue Growth
(0.21)
Return On Assets
(0.36)
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.